Evidence map›Paper›PMID 31675128›Full record

ArticleAnnals of neurology2020

α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Plasticity Sustains Severe, Fatal Status Epilepticus.

Nadia Adotevi, Ewa Lewczuk, Huayu Sun, Suchitra Joshi, Natalia Dabrowska, Sarah Shan, John Williamson, Jaideep Kapur

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Ketamine Reverses Chronic Stress-Induced Behavioral Changes via the Expression of CaFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. CaThe Journal of physiology · 2021
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nadia AdoteviDepartment of Neurology, University of Virginia, Charlottesville, VA.
Ewa LewczukDepartment of Neurology, University of Virginia, Charlottesville, VA.
Huayu SunDepartment of Neurology, University of Virginia, Charlottesville, VA.
Suchitra JoshiDepartment of Neurology, University of Virginia, Charlottesville, VA.ORCID 0000-0003-3524-2061
Natalia DabrowskaDepartment of Neurology, University of Virginia, Charlottesville, VA.
Sarah ShanCollege of Arts and Sciences, University of Virginia, Charlottesville, VA.
John WilliamsonDepartment of Neurology, University of Virginia, Charlottesville, VA.
Jaideep KapurDepartment of Neurology, University of Virginia, Charlottesville, VA.ORCID 0000-0002-8608-1352
University of Virginia · US

Funding

TREATMENT OF STATUS EPILEPTICUSR01NS040337 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KAPUR, JAIDEEP · 2000 to 2021
$5.0M
Neurosteroid Regulation of SeizuresR01NS044370 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KAPUR, JAIDEEP · 2003 to 2017
$4.1M
Progesterone receptor regulation of seizuresR01NS110863 · NINDS · UNIVERSITY OF VIRGINIA · PI JOSHI, SUCHITRA · 2019 to 2023
$1.8M
NINDS NIH HHS R01 NS040337NINDS NIH HHS R01 NS044370NINDS NIH HHS R01 NS110863
6 · The paper itself

Abstract

objectiveGeneralized convulsive status epilepticus is associated with high mortality. We tested whether α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor plasticity plays a role in sustaining seizures, seizure generalization, and mortality observed during focal onset status epilepticus. We also determined whether modified AMPA receptors generated during status epilepticus could be targeted with a drug.

methodsElectrically induced status epilepticus was characterized by electroencephalogram and behavior in GluA1 knockout mice and in transgenic mice with selective knockdown of the GluA1 subunit in hippocampal principal neurons. Excitatory and inhibitory synaptic transmission in CA1 neurons was studied using patch clamp electrophysiology. The dose response of N,N,H,-trimethyl-5-([tricyclo(3.3.1.13,7)dec-1-ylmethyl]amino)-1-pentanaminiumbromide hydrobromide (IEM-1460), a calcium-permeable AMPA receptor antagonist, was determined.

resultsGlobal removal of the GluA1 subunit did not affect seizure susceptibility; however, it reduced susceptibility to status epilepticus. GluA1 subunit knockout also reduced mortality, severity, and duration of status epilepticus. Absence of the GluA1 subunit prevented enhancement of glutamatergic synaptic transmission associated with status epilepticus; however, γ-aminobutyric acidergic synaptic inhibition was compromised. Selective removal of the GluA1 subunit from hippocampal principal neurons also reduced mortality, severity, and duration of status epilepticus. IEM-1460 rapidly terminated status epilepticus in a dose-dependent manner.

interpretationAMPA receptor plasticity mediated by the GluA1 subunit plays a critical role in sustaining and amplifying seizure activity and contributes to mortality. Calcium-permeable AMPA receptors modified during status epilepticus can be inhibited to terminate status epilepticus. ANN NEUROL 2020;87:84-96.

Indexed as

AdamantaneAmantadineAnimalsAtropineCA1 Region, HippocampalDose-Response Relationship, DrugElectric StimulationFemaleGene Knockdown TechniquesHippocampusMaleMiceMice, KnockoutNeuronal PlasticityReceptors, AMPAStatus EpilepticusAdamantaneAmantadineAtropineIEM 1460Receptors, AMPA

Identifiers

PMID31675128
PMCPMC6958551
OpenAlexW2983554196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.